Even a 2% decline in lung function predicted poor outcomes for patients with idiopathic pulmonary fibrosis (IPF) in a new ...

The findings, which add to the limited data on the burden of atopic dermatitis on adolescent and pediatric patients, showed ...

Gerard Criner, MD, FACP, FACCP, MATINEE investigator, highlights trial results that showed reduced exacerbations and delayed disease progression in patients with eosinophilic chronic obstructive ...

Patients with extensive-stage small cell lung cancer (SCLC) experienced clinically meaningful benefits with lurbinectedin ...

Assistance from artificial intelligence can potenially increase the number of patients eligible for treatment for HER2-low ...

Luspatercept showed real-world efficacy among patients with lower-risk myelodysplastic syndrome (MDS), confirming results ...

Evernorth has capped antiobesity drug monthly co-pays at $200 in a move to improve access and affordability amid new drug ...

A causal link between chronic spontaneous urticaria and gut microbiota, with metabolic pathways potentially acting as ...

Topical roflumilast 0.3% cream has been approved by the FDA to treat plaque psoriasis in patients 12 years and older since ...

FDA approves mepolizumab (Nucala; GSK) as the first monthly biologic for chronic obstructive pulmonary disease (COPD), significantly reducing exacerbations in patients with an eosinophilic phenotype.

Veterans primarily receiving care through the Department of Veterans Affairs (VA) similarly used dental and vision services ...

Kothari, PhD, highlights the need to expand Medigap access for Medicare beneficiaries younger than 65 years and calls for ...